Skip to content
10-Q

Quarterly Report

PONIARD PHARMACEUTICALS, INC.

0001193125-11-285826

← back to feed
Filed
Oct 28, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Oct 25, 2011 59.97M sh
Capex Q3 2011 · Sep 30, 2011 $9K
Capex Q3 2011 · Sep 30, 2010 $7K
Operating Cash Flow Q3 2011 · Sep 30, 2011 −$5.41M
Operating Cash Flow Q3 2011 · Sep 30, 2010 −$19.23M
Cash And Equivalents Q3 2011 · Sep 30, 2011 $1.98M
Cash And Equivalents Q3 2011 · Dec 31, 2010 $1.28M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $11.02M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $15.94M
Stockholders Equity Q3 2011 · Sep 30, 2011 $3.12M
Stockholders Equity Q3 2011 · Dec 31, 2010 $8.45M
Current Liabilities Q3 2011 · Sep 30, 2011 $2.98M
Current Liabilities Q3 2011 · Dec 31, 2010 $1.62M
Current Assets Q3 2011 · Sep 30, 2011 $2.25M
Current Assets Q3 2011 · Dec 31, 2010 $5.22M
Total Assets Q3 2011 · Sep 30, 2011 $7.74M
Total Assets Q3 2011 · Dec 31, 2010 $11.64M
Sga Expense Q3 2011 · Sep 30, 2011 $3.46M
Sga Expense Q3 2011 · Sep 30, 2011 $9.76M
Sga Expense Q3 2011 · Sep 30, 2010 $5.06M
Sga Expense Q3 2011 · Sep 30, 2010 $13.75M
Rd Expense Q3 2011 · Sep 30, 2011 $287K
Rd Expense Q3 2011 · Sep 30, 2011 $1.06M
Rd Expense Q3 2011 · Sep 30, 2010 $891K
Rd Expense Q3 2011 · Sep 30, 2010 $7.87M
Net Income Q3 2011 · Sep 30, 2011 −$3.77M
Net Income Q3 2011 · Sep 30, 2011 −$10.88M
Net Income Q3 2011 · Sep 30, 2010 −$6.45M
Net Income Q3 2011 · Sep 30, 2010 −$24.88M
Operating Income Q3 2011 · Sep 30, 2011 −$3.75M
Operating Income Q3 2011 · Sep 30, 2011 −$10.82M
Operating Income Q3 2011 · Sep 30, 2010 −$5.95M
Operating Income Q3 2011 · Sep 30, 2010 −$23.24M